Literature DB >> 19965698

Insufficient evidence to suggest less stringent therapy in hemophilia B?

Ingrid E M den Uijl, Goris Roosendaal, Kathelijn Fischer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965698     DOI: 10.1182/blood-2009-08-241240

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Prophylaxis use among males with haemophilia B in the United States.

Authors:  M Ullman; Q C Zhang; S D Grosse; M Recht; J M Soucie
Journal:  Haemophilia       Date:  2017-08-06       Impact factor: 4.287

2.  The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.

Authors:  J Michael Soucie; Paul E Monahan; Roshni Kulkarni; Barbara A Konkle; Marshall A Mazepa
Journal:  Blood Adv       Date:  2018-08-28

3.  Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX.

Authors:  Ki-Young Yoo; Soo-Young Jung; Sung-Ho Hwang; Su-Min Lee; Jong-Ho Park; Hyun-Ja Nam
Journal:  Blood Res       Date:  2018-03-27

4.  Comparison of Total Joint Replacement Rate Between Patients With Hemophilia A and Patients With Hemophilia B: A Population-Based and Retrospective Cohort Study.

Authors:  Wen-Ya Lin; Jiaan-Der Wang; Yu-Tse Tsan; Wei-Cheng Chan; Kwok-Man Tong; Shin-Tsu Chang; Yuan-Yang Cheng
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-13       Impact factor: 2.389

Review 5.  Hemophilia A and B: molecular and clinical similarities and differences.

Authors:  Giancarlo Castaman; Davide Matino
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

6.  Differences in Major Bleeding Events Between Patients With Severe Hemophilia A and Hemophilia B: A Nationwide, Population-Based Cohort Study.

Authors:  Ming-Yang Shih; Jiaan-Der Wang; Jia-De Yin; Yu-Tse Tsan; Wei-Cheng Chan
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.